Breaking News, Trials & Filings

Perrigo’s Miconazole Generic Gains FDA Approval

Perrigo Co. has received approval from the FDA for its aNDA for OTC Miconazole Nitrate Vaginal Cream and Suppository, a generic to Monistat -1 Combination Pack, for the treatment of vaginal yeast infections.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Perrigo Co. has received approval from the FDA for its aNDA for OTC Miconazole Nitrate Vaginal Cream and Suppository, a generic to Monistat -1 Combination Pack, for the treatment of vaginal yeast infections. Perrigo expects to begin shipping immediately. The approval includes 180 days of generic marketing exclusivity. Perrigo’s chairman and chief executive officer Joseph C. Papa concluded, “This is another example of Perrigo’s commitment to innovation by challenging brand pa...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters